Wired focuses on GLP-1 patient fallout

Kudos to Wired for its piece, “A Major GLP-1 Drug Shortage Is Over. Some Patients Aren’t Celebrating.” It’s all about how patients who have gotten used to the price and availability of compounded tirzepatide are now facing a double whammy of not being able to get the commercial version, and even if they can, the sticker shock hits hard.